Use of neuromuscular blockade for neck dissection and association with iatrogenic nerve injury.
Iatrogenic
Injury
Lymphadenectomy
Neck dissection
Nerve
Nerve monitoring
Neuromuscular blockade
Journal
BMC anesthesiology
ISSN: 1471-2253
Titre abrégé: BMC Anesthesiol
Pays: England
ID NLM: 100968535
Informations de publication
Date de publication:
28 07 2023
28 07 2023
Historique:
received:
29
04
2023
accepted:
20
07
2023
medline:
31
7
2023
pubmed:
29
7
2023
entrez:
28
7
2023
Statut:
epublish
Résumé
Cranial nerve injury is an uncommon but significant complication of neck dissection. We examined the association between the use of intraoperative neuromuscular blockade and iatrogenic cranial nerve injury during neck dissection. This was a single-center, retrospective, electronic health record review. Study inclusion criteria stipulated patients > 18 years who had ≥ 2 neck lymphatic levels dissected for malignancy under general anesthesia with a surgery date between 2008 - 2018. Use of neuromuscular blockade during neck dissection was the primary independent variable. This was defined as any use of rocuronium, cisatracurium, or vecuronium upon anesthesia induction without reversal with sugammadex prior to surgical incision. Univariate tests were used to compare variables between those patients with, and those without, iatrogenic cranial nerve injury. Multivariable logistic regression determined predictors of cranial nerve injury and was performed incorporating Firth's estimation given low prevalence of the primary outcome. Our cohort consisted of 925 distinct neck dissections performed in 897 patients. Neuromuscular blockade was used during 285 (30.8%) neck dissections. Fourteen instances (1.5% of surgical cases) of nerve injury were identified. On univariate logistic regression, use of neuromuscular blockade was not associated with iatrogenic cranial nerve injury (OR: 1.73, 95% CI: 0.62 - 4.86, p = 0.30). There remained no significant association on multivariable logistic regression controlling for patient age, sex, weight, ASA class, paralytic dose, history of diabetes, stroke, coronary artery disease, carotid atherosclerosis, myocardial infarction, and cardiac arrythmia (OR: 1.87, 95% CI: 0.63 - 5.51, p = 0.26). In this study, use of neuromuscular blockade intraoperatively during neck dissection was not associated with increased rates of iatrogenic cranial nerve injury. While this investigation provides early support for safe use of neuromuscular blockade during neck dissection, future investigation with greater power remains necessary.
Sections du résumé
BACKGROUND
Cranial nerve injury is an uncommon but significant complication of neck dissection. We examined the association between the use of intraoperative neuromuscular blockade and iatrogenic cranial nerve injury during neck dissection.
METHODS
This was a single-center, retrospective, electronic health record review. Study inclusion criteria stipulated patients > 18 years who had ≥ 2 neck lymphatic levels dissected for malignancy under general anesthesia with a surgery date between 2008 - 2018. Use of neuromuscular blockade during neck dissection was the primary independent variable. This was defined as any use of rocuronium, cisatracurium, or vecuronium upon anesthesia induction without reversal with sugammadex prior to surgical incision. Univariate tests were used to compare variables between those patients with, and those without, iatrogenic cranial nerve injury. Multivariable logistic regression determined predictors of cranial nerve injury and was performed incorporating Firth's estimation given low prevalence of the primary outcome.
RESULTS
Our cohort consisted of 925 distinct neck dissections performed in 897 patients. Neuromuscular blockade was used during 285 (30.8%) neck dissections. Fourteen instances (1.5% of surgical cases) of nerve injury were identified. On univariate logistic regression, use of neuromuscular blockade was not associated with iatrogenic cranial nerve injury (OR: 1.73, 95% CI: 0.62 - 4.86, p = 0.30). There remained no significant association on multivariable logistic regression controlling for patient age, sex, weight, ASA class, paralytic dose, history of diabetes, stroke, coronary artery disease, carotid atherosclerosis, myocardial infarction, and cardiac arrythmia (OR: 1.87, 95% CI: 0.63 - 5.51, p = 0.26).
CONCLUSIONS
In this study, use of neuromuscular blockade intraoperatively during neck dissection was not associated with increased rates of iatrogenic cranial nerve injury. While this investigation provides early support for safe use of neuromuscular blockade during neck dissection, future investigation with greater power remains necessary.
Identifiants
pubmed: 37507689
doi: 10.1186/s12871-023-02217-7
pii: 10.1186/s12871-023-02217-7
pmc: PMC10375630
doi:
Substances chimiques
gamma-Cyclodextrins
0
Neuromuscular Nondepolarizing Agents
0
Sugammadex
361LPM2T56
Anesthetics
0
Androstanols
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
254Informations de copyright
© 2023. The Author(s).
Références
Head Neck. 1999 Sep;21(6):499-505
pubmed: 10449664
Eur J Anaesthesiol. 2020 Mar;37(3):187-195
pubmed: 31860601
Anesth Analg. 2021 Dec 1;133(6):1437-1450
pubmed: 34784330
Medicine (Baltimore). 2021 Jul 23;100(29):e26576
pubmed: 34398011
Am J Surg. 1985 Oct;150(4):414-21
pubmed: 4051103
Dan Med J. 2020 Aug 1;67(8):
pubmed: 32741441
Anaesth Intensive Care. 2002 Apr;30(2):192-7
pubmed: 12002927
Laryngoscope. 1991 Apr;101(4 Pt 1):433-5
pubmed: 1810288
Cureus. 2020 Sep 9;12(9):e10328
pubmed: 33052289
Am J Surg. 1978 Oct;136(4):516-9
pubmed: 707734
Nat Rev Cancer. 2009 Feb;9(2):134-42
pubmed: 19148183
Laryngoscope. 2005 Feb;115(2):259-63
pubmed: 15689746
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300
pubmed: 20610543
Br J Anaesth. 2017 Oct 01;119(4):595-605
pubmed: 29121289
Anesthesiology. 2023 Jan 1;138(1):13-41
pubmed: 36520073
Anesth Analg. 2000 Nov;91(5):1250-5
pubmed: 11049917
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
Br J Anaesth. 2011 Feb;106(2):194-8
pubmed: 21068050
J Clin Med. 2021 Sep 18;10(18):
pubmed: 34575355
Anesthesiology. 2016 Oct;125(4):647-55
pubmed: 27496656
Am J Surg. 1988 Oct;156(4):286-9
pubmed: 3177752
Br J Anaesth. 2018 Jun;120(6):1381-1393
pubmed: 29793603
Thyroid. 2021 Nov;31(11):1730-1740
pubmed: 34541890
Laryngoscope. 2000 Apr;110(4):620-6
pubmed: 10764008
JAMA Dermatol. 2015 Oct;151(10):1081-6
pubmed: 25928283
Br J Anaesth. 2014 Oct;113(4):549-59
pubmed: 25204697
Arch Otolaryngol. 1961 Oct;74:424-8
pubmed: 14477989
J Abnorm Soc Psychol. 1962 Sep;65:145-53
pubmed: 13880271
Br J Anaesth. 2017 Jun 1;118(6):834-842
pubmed: 28575335
Arch Otolaryngol Head Neck Surg. 1994 Jul;120(7):699-702
pubmed: 8018319
Arch Otolaryngol Head Neck Surg. 2008 May;134(5):536-8
pubmed: 18490577
JAMA Otolaryngol Head Neck Surg. 2019 Dec 1;145(12):1137-1143
pubmed: 31045218
Am J Otolaryngol. 2022 Jan-Feb;43(1):103271
pubmed: 34800862
Head Neck. 2017 Apr;39(4):791-796
pubmed: 27987243
Anesthesiol Clin. 2021 Sep;39(3):457-476
pubmed: 34392879
J Otolaryngol Head Neck Surg. 2018 Jan 23;47(1):7
pubmed: 29361981
J Laryngol Otol. 2014 Sep;128(9):746-51
pubmed: 25170992
Radiat Oncol J. 2015 Dec;33(4):344-9
pubmed: 26756035
N Engl J Med. 2012 Jul 12;367(2):156
pubmed: 22784118
Arch Otolaryngol Head Neck Surg. 2002 Jul;128(7):751-8
pubmed: 12117328